COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34
To provide antibodies, compounds, pharmaceutical compositions and methods for treating immune-mediated diseases such as Alzheimer's disease or tauopathy diseases.SOLUTION: Provided herein is an antibody that binds to human IL-34, where the antibody comprises a heavy chain variable region (VH) a...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Japanese |
Published |
16.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To provide antibodies, compounds, pharmaceutical compositions and methods for treating immune-mediated diseases such as Alzheimer's disease or tauopathy diseases.SOLUTION: Provided herein is an antibody that binds to human IL-34, where the antibody comprises a heavy chain variable region (VH) and a light chain variable region (VL), the VH comprises a heavy chain complementarity determining region (HCDR) HCDR1, HCDR2 and HCDR3, and the VL comprises a light chain complementarity determining region (LCDR) LCDR1, LCDR2 and LCDR3. Also provided is an agent for treating an immune-mediated disease selected from the group consisting of Alzheimer's disease, a tauopathy disease, Sjogren syndrome (SS), rheumatoid arthritis (RA), inflammatory bowel disease (IBD), atopic dermatitis, kidney diseases, sepsis, and/or non-alcoholic fatty liver disease (NAFLD).SELECTED DRAWING: None
【課題】アルツハイマー病又はタウオパチー疾患などの免疫介在性疾患を治療するための抗体、化合物、医薬組成物及び方法を提供する。【解決手段】ヒトIL-34に結合する抗体であって、前記抗体が、重鎖可変領域(VH)と、軽鎖可変領域(VL)と、を含み、前記VHが、重鎖相補性決定領域(HCDR)HCDR1、HCDR2、及びHCDR3を含み、前記VLが、軽鎖相補性決定領域(LCDR)LCDR1、LCDR2、及びLCDR3を含む、抗体を提供する。また、前記抗体を含む、アルツハイマー病、タウオパチー病、シェーグレン症候群(SS)、関節リウマチ(RA)、炎症性腸疾患(IBD)、アトピー性皮膚炎、腎疾患、敗血症、及び/又は非アルコール性脂肪性肝疾患(NAFLD)からなる群から選択される免疫介在性疾患の治療剤を提供する。【選択図】なし |
---|---|
Bibliography: | Application Number: JP20220172479 |